Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121

2017 Biggest Healthcare Deals by Sector

by | Jan 29, 2018 10:09 am | Behavioral Health Care, Biotechnology, eHealth, Long-Term Care, Managed Care, Medical Devices, Other Services, Pharmaceuticals, Physician Medical Groups, Rehabilitation

2017 was another big year for billion-dollar healthcare transactions. Among the deals that disclosed prices, 44 topped the billion-dollar mark, for a total of approximately $263.1 billion. Although that number seems high, there were 50 billion-dollar deals announced in 2015, although those totaled a slightly lower $240.1 billion. 2016 posted lower totals for both the number of billion-dollar deals (39) and combined prices ($194.1 billion). Of course the biggest healthcare deal in 2017 was the $77 billion acquisition of Aetna Inc. (NYSE: AET) by CVS Health (NYSE: CVS). But there were many more sizable transactions across the sectors, as the chart below illustrates. See how many you remember... Read More »
Deal of the Week: Elsevier/Via Oncology

Deal of the Week: Elsevier/Via Oncology

by | Jan 19, 2018 2:07 pm | eHealth

Deal makers took a break last week, after a long trudge through the J.P. Morgan Healthcare Conference the week before. Deal volume was light in the week of Janaury 17, 2018, but at least 70 transactions have been recorded this month. Here’s an unusual deal from the eHealth sector we picked. Elsevier, a subsidiary of RELX plc (NYSE: RELX), announced its acquisition of Via Oncology, a privately held, former subsidiary of UPMC, based in Pittsburgh. Elsevier is a global provider of information solutions for science, health and technology professionals. Via Oncology provides decision support tools for cancer. Specifically, its Via Pathways product helps cancer centers demonstrate the... Read More »
Allscripts Adds Practice Fusion

Allscripts Adds Practice Fusion

by | Jan 15, 2018 2:04 pm | eHealth

Allscripts Healthcare Solutions (NASDAQ: MDRX) is back in buying mode. The healthcare technology company announced two deals back in August 2017, picking off McKesson’s (NYSE: MCK) hospital and health IT portfolio for $185 million, and then NantHealth’s (NASDAQ: NH) electronic health record (EHR) assets for an undisclosed price. This time, the target is Practice Fusion, a Silicon Valley startup focused on creating affordable certified cloud-based EHR systems for small, independent physician practices. As small as that market may seem, the company now supports 30,000 ambulatory practices and 5 million patient visits per month. The deal is a strategic one for Allscripts,... Read More »
Allscripts Adds Practice Fusion

eHealth Deals Dipped in Q3:2017

by | Nov 9, 2017 9:22 pm | eHealth

Merger and acquisition activity in the eHealth sector decreased in the third quarter, down 5% compared with the previous quarter, to 42 deals. However, the quarter’s results were 45% higher than the same period a year earlier. The third quarter’s total represents a 26% share of the 164 deals announced in the previous 12 months. Information technology underpins every aspect of the healthcare industry, as it does in virtually every other market. The repeal-and-replace effort has had little impact on investor interest in this sector, as technology stocks continue to dominate the equity markets. Source: HealthCareMandA.com, October 2017 Of the 42 deals announced in Q3:17, only seven disclosed... Read More »
Deal of the Week: Elsevier/Via Oncology

Clinical Trial Software Companies Are Hot

by | Nov 3, 2017 4:55 pm | Biotechnology, CRO, eHealth

The digital health sector is benefitting big-time from the explosion in drug discovery transactions in 2017. Investors are now targeting eHealth companies specializing in clinical trial software. The statistics behind the surge in mergers and acquisitions in the drug discovery market are impressive. Through the first week in November, 43 deals targeting contract research organizations (CROs) have been announced, up nearly 70% from this time in 2016, and a 760% increase from this time in 2015. Biotechnology deals are speeding up as well, up nearly 30% from the past two years. Pharmaceutical companies are a main driver of demand in these sectors. Rather than fund in-house R&D, Big Pharma... Read More »
Allscripts Adds Practice Fusion

Azalea Health Adds to its EMR Offerings

by | Oct 13, 2017 6:03 pm | eHealth

Digital health deals are on track to surpass 2016’s record 157 transactions. Through mid-October, 139 deals have been announced in this sector, targeting companies specializing in revenue cycle management, telemedicine and electronic medical records (EMRs). Just four companies have made more than one acquisition this year, indicating there are more buyers getting into digital health than leaving it. Among the four serial acquirers this year are Allscripts (NASDAQ: MDRX), Azalea Health, NextGen Healthcare Information (NASDAQ: QSII) and contract research organization PRA Health Sciences (NASDAQ: PRAH). Azalea Health is the only the privately held digital health company to announce... Read More »